Amneal and Impax merge to become ‘fifth largest’ generics company

19-10-2017

Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US.


Amneal, Impax, generics, M&A, Chirag Patel, Paul Bisaro

LSIPR